Evidence map›Paper›PMID 32734338›Full record

ReviewPediatric surgery international2020

Tissue engineering: from the bedside to the bench and back to the bedside.

Tatevik Sahakyants, Joseph P Vacanti

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pediatric surgery international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Decellularization of the human urethra for tissue engineering applications.Experimental biology and medicine (Maywood, N.J.) · 2023
    Article
  7. Article
  8. Tissue engineering of human ear pinna.Cell and tissue banking · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tatevik SahakyantsLaboratory for Tissue Engineering and Organ Fabrication, Massachusetts General Hospital (MGH), 3D BioLabs, LLC, 700 Main Street, Cambridge, MA, 02139, USA.
Joseph P VacantiDepartment of Pediatric Surgery, Laboratory for Tissue Engineering and Organ Fabrication, Harvard Medical School, Massachusetts General Hospital (MGH), MassGeneral Hospital for Children, 55 Fruit Street, Warren 11, Boston, MA, 02114, USA. jvacanti@partners.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of Tissue Engineering and Regenerative Medicine has evolved rapidly over the past thirty years. This review will summarize its history, current status and direction through the lens of clinical need, its progress through science in the laboratory and application back into patients. We can take pride in the fact that much effort and progress began with the surgical problems of children and that many surgeons in the pediatric surgical specialties have become pioneers and investigators in this new field of science, engineering, and medicine. Although the field has yet to fulfill its great promise, there have been several examples where a therapy has progressed from the first idea to human application within a short span of time and, in many cases, it has been applied in the surgical care of children.

Indexed as

ChildHumansPoint-of-Care SystemsRegenerative MedicineTissue EngineeringBlood vesselsComplex tissuesEarSkinTissue engineering

Identifiers

PMID32734338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.